# A Post-treatment Program to Identify and Manage Complications Related to Oncology or Hematology Treatments in Cancer Survivors.

> **NCT04671693** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Centre Leon Berard** · enrollment: 500 (actual)

## Conditions studied

- Late Effects
- Testicular Germ Cell Tumor Mixed
- Non-Metastatic Breast Carcinoma
- Soft Tissue Sarcoma, Adult, Stage IIC
- Osteosarcoma
- Ewing's Sarcoma
- Acute Myeloid Leukemia
- Hodgkin Disease
- Non Hodgkin Lymphoma

## Interventions

- **OTHER:** PASCA intervention

## Key facts

- **NCT ID:** NCT04671693
- **Lead sponsor:** Centre Leon Berard
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2020-12-24
- **Primary completion:** 2029-01-24
- **Final completion:** 2029-04-24
- **Target enrollment:** 500 (ACTUAL)
- **Last updated:** 2025-09-05

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04671693

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04671693, "A Post-treatment Program to Identify and Manage Complications Related to Oncology or Hematology Treatments in Cancer Survivors.". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT04671693. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*